Inmunogenicidad de la vacuna frente al virus de la hepatitis B en pacientes con enfermedad inflamatoria intestinal

Bachelor thesis Spanish; Castilian OPEN
Olsen Rodríguez, Renée;
(2017)
  • Subject: Vacuna | Enfermedad de Crohn | Virus de la hepatitis B | Colitis ulcerosa
La colitis ulcerosa (CU) y la enfermedad de Crohn (EC) son patologías que se denominan conjuntamente enfermedad inflamatoria intestinal (EII). Su patogenia es poco conocida, pero si se sabe que hay una respuesta inmune frente a estructuras del tubo digestivo. El tratami... View more
  • References (10)

    1. Vida Pérez L, Gómez Camacho F, García Sánchez V, Flores I, M.a E, Castillo Molina L, et al. Eficacia de la vacuna contra el virus de la hepatitis B en pacientes con enfermedad inflamatoria intestinal. Med Clínica. :331-5.

    2. Farreras-Rozman. Medicina Interna. Volumen I. 17º edición. Elsevier. Barcelona. 2012

    3. Marín AC, Gisbert JP, Chaparro M. Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease. World J Gastroenterol WJG. 2015 Oct 28;21(40):11273-81.

    4. Gisbert JP, Chaparro M, Esteve M. Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2011 Mar;33(6):619-33.

    5. Millonig G, Kern M, Ludwiczek O, Nachbaur K, Vogel W. Subfulminant hepatitis B after infliximab in Crohn's disease: Need for HBV-screening? World J Gastroenterol WJG. 2006 Feb 14;12(6):974-6.

    6. Cossio-Gil Y, Martínez-Gómez X, Campins-Martí M, Rodrigo-Pendás JÁ, Borruel-Sainz N, Rodríguez-Frías F, et al. Immunogenicity of hepatitis B vaccine in patients with inflammatory bowel disease and the benefits of revaccination. J Gastroenterol Hepatol. 2015 Jan;30(1):92-8.

    7. Rahier JF, Magro F, Abreu C, Armuzzi A, Ben-Horin S, Chowers Y, et al. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2014 Jun;8(6):443-68.

    8. Carrera E, Manzano R, Garrido E. Efficacy of the vaccination in inflammatory bowel disease. World J Gastroenterol. 2013 Mar 7;19(9):1349-53.

    9. Ben Musa R, Gampa A, Basu S, Keshavarzian A, Swanson G, Brown M, et al. Hepatitis B vaccination in patients with inflammatory bowel disease. World J Gastroenterol WJG. 2014 Nov 7;20(41):15358-66.

    11. Cekic C, Aslan F, Krc A, Gümüs ZZ, Arabul M, Yüksel ES, et al. Evaluation of factors associated with response to hepatitis B vaccination in patients with inflammatory bowel disease. Medicine (Baltimore). 2015 Jun;94(22):e940. Altunöz ME, Senateş E, Yeşil A, Calhan T, Ovünç AOK. Patients with inflammatory bowel disease have a lower response rate to HBV vaccination compared to controls. Dig Dis Sci. 2012 Apr;57(4):1039-44. Sánchez-Tembleque MD, Corella C, Pérez-Calle JL. Vaccines and recommendations for their use in inflammatory bowel disease. World J Gastroenterol. 2013 Mar 7;19(9):1354-8.

  • Metrics
Share - Bookmark